In this study, we hypothesized that androgens cause expansion and dysfunction of WAT in SAT and VAT via mitochondrial dysfunction and oxidative stress and that SGLT2 inhibition reverses these processes in the PCOS model. The gene discussed is SLC5A2; the disease is polycystic ovary syndrome.